Polymeric micelle for tumor pH and folate-mediated targeting
Novel pH-sensitive polymeric mixed micelles composed of poly( l-histidine) (polyHis; M w 5000)/PEG ( M n 2000) and poly( l-lactic acid) (PLLA) ( M n 3000)/PEG ( M n 2000) block copolymers with or without folate conjugation were prepared by diafiltration. The micelles were investigated for pH-depende...
Gespeichert in:
Veröffentlicht in: | Journal of controlled release 2003-08, Vol.91 (1), p.103-113 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Novel pH-sensitive polymeric mixed micelles composed of poly(
l-histidine) (polyHis;
M
w 5000)/PEG (
M
n 2000) and poly(
l-lactic acid) (PLLA) (
M
n 3000)/PEG (
M
n 2000) block copolymers with or without folate conjugation were prepared by diafiltration. The micelles were investigated for pH-dependent drug release, folate receptor-mediated internalization and cytotoxicity using MCF-7 cells in vitro. The polyHis/PEG micelles showed accelerated adriamycin release as the pH decreased from 8.0. When the cumulative release for 24 h was plotted as a function of pH, the gradual transition in release rate appeared in a pH range from 8.0 to 6.8. In order to tailor the triggering pH of the polymeric micelles to the more acidic extracellular pH of tumors, while improving the micelle stability at pH 7.4, the PLLA/PEG block copolymer was blended with polyHis/PEG to form mixed micelles. Blending shifted the triggering pH to a lower value. Depending on the amount of PLLA/PEG, the mixed micelles were destabilized in the pH range of 7.2–6.6 (triggering pH for adriamycin release). When the mixed micelles were conjugated with folic acid, the in vitro results demonstrated that the micelles were more effective in tumor cell kill due to accelerated drug release and folate receptor-mediated tumor uptake. In addition, after internalization polyHis was found to be effective for cytosolic ADR delivery by virtue of fusogenic activity. This approach is expected to be useful for treatment of solid tumors in vivo. |
---|---|
ISSN: | 0168-3659 1873-4995 |
DOI: | 10.1016/S0168-3659(03)00239-6 |